Volume 27, Issue 3 (Iran South Med J 2025)
Iran South Med J 2025, 27(3): 189-196 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Keikhaei Dehdezi B, Khodadadi A, Farhadi Kia A, Abbasi F, Bitraf S, Salehi Kahyesh R. Hemophilia A Haplotypes in Southwestern Iran. Iran South Med J 2025; 27 (3) :189-196
URL: http://ismj.bpums.ac.ir/article-1-2053-en.html
URL: http://ismj.bpums.ac.ir/article-1-2053-en.html
Bizhen Keikhaei Dehdezi1 
, Ali Khodadadi , Arta Farhadi Kia2 , Faezeh Abbasi3 , Saeed Bitraf3 , Roya Salehi Kahyesh *4
, Ali Khodadadi , Arta Farhadi Kia2 , Faezeh Abbasi3 , Saeed Bitraf3 , Roya Salehi Kahyesh *4
1- Thalassemia & Hemoglobinopathy Research center, Health Research Institute, Ahvaz Jundishapur Uni-versity
2- Department of General Medicine, School of Medicine, Izmir University of Economics, Izmir, Türkiye
3- Thalassemia & Hemoglobinopathy Research center, Health Research Institute, Ahvaz Jundishapur Uni-versity of Medical Sciences, Ahvaz, Iran
4- Thalassemia & Hemoglobinopathy Research center, Health Research Institute, Ahvaz Jundishapur Uni-versity of Medical Sciences, Ahvaz, Iran ,royaarta@yahoo.com
2- Department of General Medicine, School of Medicine, Izmir University of Economics, Izmir, Türkiye
3- Thalassemia & Hemoglobinopathy Research center, Health Research Institute, Ahvaz Jundishapur Uni-versity of Medical Sciences, Ahvaz, Iran
4- Thalassemia & Hemoglobinopathy Research center, Health Research Institute, Ahvaz Jundishapur Uni-versity of Medical Sciences, Ahvaz, Iran ,
Abstract: (670 Views)
Background: Hemophilia A has received attention in Iran due to its significant patient population and number of complications and comprises a major healthcare challenge in the southwestern region. Several factors contribute to the prevalence and incidence of hemophilia A in southwestern Iran, including genetic predisposition, consanguineous marriages, and limited access to comprehensive healthcare services. This study aimed to investigate the common haplotypes of hemophilia A in this region of our country.
Materials and Methods: Medical record data of patients with hemophilia A over 14 years from 2009 to 2023 were entered into a questionnaire, including age, gender, form or severity of the disease, the most common bleeding site, survival rate, cause of death, place of residence, blood type, ethnicity, family relationship, and mutation type. The severity of the disease was determined based on the results of the patient's factor VIII levels, and the mutation type was determined based on molecular testing and sequencing (mutation determination by direct method or gene linkage study, including VNTR).
Results: Of the 40 patients in this study, three were female (7.5%), and 37 were male (92.5%). The most common disease form was severe. In 39 patients, the most common bleeding site was in the joints, and only one case had bleeding in the gastrointestinal tract. A high mutation diversity was observed in gene mutations and inversions; the most reported case was intron-22 gene inversion.
Conclusion: Identifying genetic mutations in hemophilia disease helps promote the clinical care available for these patients. Genetic testing is also indicated for carrier identification and prenatal diagnosis.
Type of Study: Original |
Subject:
Hematology and laboratory sciences
Received: 2024/10/15 | Accepted: 2025/01/1 | Published: 2025/01/25
Received: 2024/10/15 | Accepted: 2025/01/1 | Published: 2025/01/25
References
1. Bovenschen N, Herz J, Grimbergen JM & et al. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. Blood 2003; 101(10): 3933-9. [DOI]
2. Iorio A, Stonebraker JS, Chambost H & et al. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. Ann Intern Med 2019; 171(8): 540-6. [DOI]
3. Morange PE, Tregouet DA, Frere C & et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol. 2005; 128(1): 91-9. [DOI]
4. Schambeck CM, Hinney K, Haubitz I & et al. Familial clustering of high factor VIII levels in patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 2001; 21(2): 289-92. [DOI]
5. Shen BW, Spiegel PC, Chang CH & et al. The tertiary structure and domain organization of coagulation factor VIII. Blood 2008; 111(3): 1240-7. [DOI]
6. Salimi R, Zolfaghari B, Isfahani H & et al. Frequency of primary clinical manifestations of bleeding diseases in patients referred to Besat Hospital in Hamadanin 2020-2021. Sci J Iran Blood Transfus Organ 2022; 19(2): 122-130. [Article]
7. Hazendonk HC, Lock J, Mathôt RA & et al. Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications. J Thromb Haemost 2016 Mar; 14(3): 468-78. [DOI]
8. Franchini M, Coppola A, Santoro C & et al. ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers. Semin Thromb Hemost 2021; 47(1): 84-89. [DOI]
9. Ray D, Kumar N, Hans C & et al. Impact of ABO blood group antigens on residual factor VIII levels and risk of inhibitor development in hemophilia A. Blood res 2023; 58(1): 61-70. [DOI]
10. Wu O, Bayoumi N, Vickers MA & et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6(1): 62-9. [DOI]
11. Lenting PJ, Christophe OD, Denis CV. Von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood 2015; 125(13): 2019- 28. [DOI]
12. Martenez-Sanchez LM, Cardona-Velez J, RamirezPulgarin S & et al. Clinical and epidemiological profile of patients with hemophilia in Liga de Hemofilicos de Antioquia (Colombia). Revista Medica de Risaralda 2017; 23(1): 34-7. [Article]
13. Sona PS, Lingam CM. Hemophilia-An overview. IJPSRR 2010; 5(1): 18-26. [Article]
14. Bicocchi MP, Pasino M, Lanza T & et al. Analysis of 18 novel mutations in the factor VIII gene. Br J Haematol 2003; 122(5): 810-7. [DOI]
15. Azimifar SB, Seyedna SY, Zeinali S. Allele frequencies of three factor VIII gene polymorphisms in Iranian populations and their application in hemophilia A carrier detection. Am J Hematol 2006; 81(5): 335-9. [DOI]
16. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC & et al. Cardiovascular disease in patients with hemophilia. J Thromb Haemost 2009; 7(2): 247-54. [DOI]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
